The Filing Desk

CareDx vs Castle Biosciences

CareDx CDNA · Castle Biosciences CSTL · Health Care Services

CareDx reported revenue of $380 million in fiscal 2025, about the same as Castle Biosciences' $344 million in fiscal 2025. CareDx's revenue grew 13.8% in its latest year, and Castle Biosciences' grew 3.7%. CareDx had an operating margin of -8.1%, against -12.4% at Castle Biosciences.

Side by side

CareDxCastle Biosciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$380M$344M
Revenue growth13.8%3.7%
Revenue growth a year, last 5 years14.6%40.6%
Gross margin—79.4%
Operating margin−8.1%−12.4%
Net margin−5.6%−7.0%
Free cash flow—$28M
Free cash flow margin—8.2%
Return on capital−20.0%−19.1%
Net debt to EBITDA——
Dividends and buybacks$88M$0M
Change in diluted share count−5.9%−0.9%
Last close$77.88$33.79
P/E at the last close32.6×—
Insider trades, last 12 monthssold $13.6 million—
Piotroski F-score4 of 84 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CareDxCastle Biosciences
Operating margin
Percent of revenue
CareDxCastle Biosciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CareDxCastle Biosciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CareDx and Castle Biosciences pages.